(Q34275998)

1 August 2017

1 reference

title

Rheumatoid arthritis. From bench to bedside (English)

1 reference

1 August 2017

1 reference

McInnes IB

1

1 reference

1 August 2017

publication date

1 May 2001

1 reference

Rheumatic Diseases Clinics of North America

1 August 2017

published in

1 reference

1 August 2017

volume

27

1 reference

1 August 2017

issue

2

1 reference

1 August 2017

page(s)

373-387

1 reference

Inhibition of the production and effects of interleukin-1 and tumor necrosis factor alpha in rheumatoid arthritis

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti-tumour necrosis factor-alpha (cA2) therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Macrophage-derived cytokine and nuclear factor kappaB p65 expression in synovial membrane and skin of patients with psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Cytokines and direct cell contact in synovitis: relevance to therapeutic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

1 reference

7 January 2021

Role of cytokines in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

The role of T cells in the immunopathogenesis of rheumatoid arthritis: new perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

A proinflammatory role for IL-18 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Evidence for the continuous recruitment and activation of T cells into the joints of patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Immunoregulatory role of interleukin 10 in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Differential regulation of rheumatoid synovial cell interleukin-12 production by tumor necrosis factor alpha and CD40 signals

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Review: angiogenesis: implications for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Asymptomatic synovitis precedes clinically manifest arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Immunohistological analysis of synovial tissue for differential diagnosis in early arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

CCR5 is characteristic of Th1 lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Anti-cytokine therapy for rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Classification of inflammatory arthritis by enthesitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Innate response cytokines in inflammatory synovitis: a role for interleukin-15.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Cell-cell interactions in synovitis. Interactions between T lymphocytes and synovial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Interleukin 18: a pleiotropic participant in chronic inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

The role of interleukin–15 in T–cell migration and activation in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Are T cells in rheumatoid synovium aggressors or bystanders?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Anticytokine therapy--a new era in the treatment of rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells In vitro and in the SCID mouse-human rheumatoid arthritis model In vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Distinct vascular patterns of early synovitis in psoriatic, reactive, and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Direct contact between T lymphocytes and human dermal fibroblasts or synoviocytes down-regulates types I and III collagen production via cell-associated cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

CD40-CD40 ligand (CD154) engagement is required but may not be sufficient for human T helper 1 cell induction of interleukin-2- or interleukin-15-driven, contact-dependent, interleukin-1beta production by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Analysis of the cellular infiltrates and expression of cytokines in synovial tissue from patients with rheumatoid arthritis and reactive arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Current perspectives on synovitis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Combination Therapy with Cyclosporine and Methotrexate in Severe Rheumatoid Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Role of interleukin-1, tumor necrosis factor alpha, and interleukin-6 in cartilage proteoglycan metabolism and destruction. Effect of in situ blocking in murine antigen- and zymosan-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Prognostic value of Th1/Th2 ratio in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

Selective expression and functions of interleukin 18 receptor on T helper (Th) type 1 but not Th2 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

T cells: pathogenic cells and therapeutic targets in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-857X%2805%2970207-6

7 January 2021

10.1016/S0889-857X(05)70207-6

Identifiers

DOI

1 reference

1 August 2017

1 reference